Sanofi said it is considering selling its animal health and European generic drug business as part of a new strategy to refocus the company on fewer markets, and the French drug maker warned of flat profit over the next two years.
from WSJ.com: US Business http://ift.tt/1SvkHOr
via IFTTT
No comments:
Post a Comment